China Pharmaceutical Group Ltd, along with its Weisheng Pharmaceutical unit, has lost its bid for dismissal of antitrust claims in a vitamin C price-fixing lawsuit.
US District Judge Brian M. Cogan in Brooklyn on Wednesday denied the Hong Kong-based parent's request to be dismissed from the suit. China Pharmaceutical, Weisheng and at least two other Chinese companies are scheduled to go on trial on Nov 5 over allegations they inflated prices for bulk vitamin C.
The companies were dominant players in a roughly $500 million global market for the material, buyers have said in the case.
Agencies - China Daily
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 130349 
